Individuals Coming Off Slimming Injections Gain Back Pounds Far More Rapidly Compared to Dieters

Fresh analysis indicates that patients who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who stop conventional lifestyle programs.

Research printed in a prominent medical journal points out that while obese individuals can lose a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month once they quit.

"Individuals using such drugs must be aware of the risk of quick rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.

That rate of regain suggests a reversion to pre-treatment weight in about one and a half years.

Weighing Approaches

The analysis, which examined dozens of studies involving thousands of participants, contrasted the effects of these new drugs with conventional dieting.

The team emphasize that people who lose weight through dieting generally see a less rapid weight regain—perhaps 100 grams monthly—post-intervention.

Explaining the Rapid Rebound

Doctors believe the mechanism of the jabs is key to understanding the amplified weight return.

GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of GLP-1 levels far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating far more likely."

An Ongoing Condition?

The NHS suggest the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.

Many experts say that, due to the high risk of relapse, the therapy is often long-term.

This opinion is echoed by pharmaceutical companies, who note that the results "underscore the long-term character of obesity," similar to managing diseases like diabetes.

User Testimonies

Individuals who have come off the medication describe a intense resurgence of cravings.

"It was like a trigger that goes on and you're instantly extremely hungry," said one woman.

This challenge is compounded if individuals have not adopted sustainable lifestyle or habit modifications during therapy.

Growing Use

Recent estimates suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.

• Use is higher among women compared to men.
• The 40s and 50s age group shows the highest level of interest.
• A large proportion access the medications through private healthcare rather than the NHS.

Ultimately, researchers emphasize that while these medications are effective agents for shedding pounds, they are not a standalone cure and long-term success hinges on ongoing behavioural changes.